INTRODUCTION
============

The main aim of this review is to propose a critical discussion of the most recent studies investigating the presence of alexithymia in patients affected by fibromyalgia (FM) syndrome, and its relation to psychological disorders, frequently observed in these patients.

Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain, with an unknown etiology ([@B49], [@B49]), while alexithymia is an affective dysregulation, characterized by difficulties in identifying and communicating feelings, and externally oriented thinking ([@B42]).

Using the keywords "Fibromyalgia," "Alexithymia," and "Psychological Distress," the Medline/Pubmed database was searched for studies examining the prevalence of alexithymia in FM patients published up to October 2012 which were then analyzed. In particular, target articles were searched using the following associations: fibromyalgia AND alexithymia, fibromyalgia AND psychological distress, fibromyalgia AND alexithymia AND psychological distress. Abstracts were checked and reviews, comments, and studies not concerning the relationship between fibromyalgia, alexithymia, and psychological distress were excluded. Seven studies were ultimately included in this review.

FIBROMYALGIA SYNDROME
=====================

Fibromyalgia is a syndrome characterized by chronic, widespread musculoskeletal pain with tenderness over specific trigger points ([@B32]; [@B33]). Its prevalence is estimated to be between 3 and 6% of the world population ([@B48]), predominantly in women, with a female to male ratio of 10:1 ([@B29]; [@B3]). It is most commonly diagnosed between the ages of 20 and 50, though onset can occur in childhood.

Fibromyalgia symptoms are not restricted to pain, but often include a heterogeneous series of other conditions, such as hyperalgesia and/or allodynia, physical and mental fatigue, disrupted or non-restorative sleep, headaches, irritable bowels, cognitive impairments, and other functional complaints ([@B32]), in the absence of laboratory or radiologic examinations to support them ([@B1]). The etiology of this syndrome is not completely understood, but clinicians and researchers believe that it could result from different factors, such as stress, medical illness, pain conditions, and a variety of neurotransmitter and neuroendocrine disturbances ([@B32]).In particular, high levels of stress and psychiatric symptoms may negatively influence the perception of disease severity ([@B15]), functional ability ([@B23]), and pain threshold and tolerance ([@B12]). Some authors suggest that the development of FM might stem from stress-induced disruption of the hypothalamic-pituitary-adrenal (HPA) axis ([@B31]). Exposure to prolonged stressful conditions can indeed alter the function of the HPA axis, with consequent increased production of the corticotrophin-releasing factor (CRF) and a potentially amplified pain perception. For this reason, FM is often defined a "*central sensitization syndrome*," caused by increased sensitivity in the central nervous system to pain signals ([@B34]).

Depressive and anxiety disorders ([@B13]), as well as elevated levels of alexithymia ([@B39]; [@B36]; [@B17]; [@B10]), have been reported, among psychological factors, as features largely present in FM syndrome.

ALEXITHYMIA
===========

Alexithymia is a personality dimension characterized by different cognitive and emotional features, observed in many clinical conditions, especially in psychosomatic disorders ([@B43]). [@B40] coined the term alexithymia, literally "absence of words for emotion," to describe people who lack the ability to communicate their feelings or have limited imagination ([@B24]). The main aspects of alexithymia, which can be considered a deficit in cognitive processing and emotions regulation ([@B18]), are a difficulty in identifying and describing subjective feelings, a difficulty distinguishing between feelings and the bodily sensations of emotional arousal, restricted imagination processes, as evidenced by a lack of imagination, and a stimulus-bound, externally oriented cognitive style ([@B45]). Alexithymic individuals are therefore incapable of adequately identifying physical sensations such as the somatic manifestations of emotions and may tend to misinterpret their emotional arousal as signs of disease ([@B28]). This makes them susceptible to incorrectly attributing emotion-related physical symptoms to physical disease and to seeking medical care for symptoms for which no medical explanations can be found ([@B46]).

The presence of alexithymic traits can be assessed with different instruments such as observer-rated measures, including the Observer Alexithymia Scale ([@B14]) and the Toronto Structured interview for Alexithymia ([@B7]), or self-report measures, including the Levels of Emotional Awareness Scale (LEAS; [@B20]) to evaluate written emotional response, or the 20-item Toronto Alexithymia Scale (TAS-20; [@B5],[@B6]).

Of these different instruments, the TAS-20 is one of the most commonly used by clinicians and researchers, and was the principal method employed to assess alexithymia in the studies analyzed. It provides investigators with a reliable, validated, and common metric for measuring the construct ([@B44]; [@B26]). The TAS-20 consists of three subscales: *difficulty identifying feelings*(F1), which measures the inability to distinguish between specific emotions, or between emotions and the bodily sensations of emotional arousal; *difficulty describing feelings*(F2), which assesses the inability to verbalize one's emotions to others; and *externally oriented thinking*(F3), which evaluates the tendency of individuals to focus their attention externally and not on the inner emotional experience ([@B44]; [@B26]).

FIBROMYALGIA SYNDROME AND ALEXITHYMIA
=====================================

Psychiatric disorders and psychological distress are some of the predominant features of FM, which may contribute to the manifestation, retention, and intensification of the symptomatology ([@B13]; [@B2]).

Among the psychological factors, alexithymia is a personality construct which has been minimally explored in FM but is worth examining, as it can interfere with the perception of emotional sensations.

The inability to emotionally regulate, especially negative feelings, is thought to result in increased negative affects, chronic sympathetic hyperarousal, and impaired immune status, which can lead to the development or exacerbation of somatic disease and pain ([@B28]; [@B17]). On the other hand, alexithymia could promote maladaptive illness behaviors, defined as a patient's ideas, affects, attitudes, and behaviors in relation to illness and the sick role, since alexithymic individuals may focus on, amplify, or overreact to unpleasant physical sensations ([@B37]).

To date, different studies have investigated the presence of alexithymia in FM patients, using distinct experimental procedures. Of the seven studies selected for the current review, three assessed alexithymia rates comparing FM patients to patients with other chronic pain conditions, one compared alexithymia levels comparing FM patients to healthy controls and three evaluated the prevalence of alexithymia comparing FM patients' values to normative data from healthy populations. In all these studies, the assessment of alexithymia was based on the use of TAS-20 (see **Table [1](#T1){ref-type="table"}**).

###### 

Examined studies concerning the multivariate relationship between FM syndrome and alexithymia (TAS-20).

  Study                                                                              Subjects                                   Results
  ---------------------------------------------------------------------------------- ------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Patients with other chronic pain conditions as control group (three studies)**                                              
  [@B39]                                                                             50 FM patients                             Significant higher alexithymia scores (total and factor 1 scores) in FM compared to both control groups.
                                                                                     20 rheumatoid arthritis patients           
                                                                                     42 healthy controls                        
  [@B41]                                                                             48 FM patients                             44% of alexithymia in FM group vs. 8% in general medicine group and 21% in rheumatoid arthritis group. Alexithymia was strongly associated with moderate to severe depression.
                                                                                     36 general medicine patients               
                                                                                     43 rheumatoid arthritis patients           
  [@B46]                                                                             70 FM patients                             Significant higher alexithymia scores in FM sample compared to both CLBP and healthy control groups.
                                                                                     56 chronic low back pain (CLBP) patients   
                                                                                     72 healthy controls                        
  **Healthy controls (one study)**                                                                                              
  [@B30]                                                                             42 FM patients                             No differences in alexithymia scores between FM group and healthy controls.
                                                                                     48 healthy controls                        
  **No control group (three studies)**                                                                                          
  [@B36]                                                                             40 FM patients                             15% of alexithymia in FM group.
  [@B17]                                                                             68 FM patients                             Significant differences only on the 1 factor of TAS-20.
  [@B10]                                                                             55 FM patients                             20% of alexithymia in FM group.

The studies listed in the table obtained, at least in part, distinct results. In particular, one study did not find differences between FM patients and the control group ([@B30]), four found significant differences ([@B39]; [@B36]; [@B17]; [@B10]), and two found unclear results ([@B41]; [@B46]).

[@B30] found no differences in alexithymia scores in a group of 42 female FM patients compared with an age-matched random sample of female healthy controls and did not report data on different subscales scores of TAS-20. A high positive correlation was detected between alexithymia scores and scores for anxiety, depression, and neuroticism, allowing the authors to suppose that alexithymia could be associated with psychological distress.

On the other hand, [@B39], found significantly higher alexithymia scores and more difficulties in identifying feelings among FM patients with respect to rheumatoid arthritis patients or healthy controls. Moreover, the rate of alexithymia did not change when the severity of pain or the level of depression were controlled for FM patients, showing that alexithymia in the FM sample examined was independent of depression or pain. [@B36] also found a higher prevalence of alexithymia in a sample of female FM patients (15%) compared to values observed in non-clinical populations (7.9%; [@B38]). In addition, they highlighted the presence of a possible relation between dysfunctional emotional regulation, the core feature of alexithymia, and problematic early relationships in the parental bonding process in FM patients. Whereas [@B17] found that a significant difference was present between the sample of female FM patients recruited and the Italian healthy normative data (see [@B9]), but only on the "difficulty identifying feeling" (DIF) subscale of the TAS-20. In addition, alexithymia -- the DIF subscale in particular -- was associated with increased affective pain and hypochondriacal illness behavior.

In line with other evidence ([@B28], [@B26]), the authors considered the former relationship to be the result of an excessive focus of alexithymics on their body or a tendency to misinterpret bodily sensations of emotional arousal as symptoms of physical illness and thought it could be mediated by psychological distress and illness behavior. Similarly, [@B10] reported a higher prevalence of alexithymia in a female FM sample (20%) with respect to the general population (see above); in this case, too, the difference was mainly due to difficulties in identifying feelings in FM patients, whereas the other subcomponents of the TAS-20, "difficulty describing feeling" and "externally oriented thinking," were not significantly different from normative data.

Of the three studies that enrolled a sample of patients affected by chronic pain conditions, without a psychosomatic component \[i.e., rheumatoid arthritis and chronic low back pain (CLBP)\], [@B41] found that the prevalence of alexithymia in FM patients was significantly higher than in either the general medicine group or the rheumatoid arthritis group. However, the higher level of alexithymia seen in the FM sample appeared only after the presence of moderate to severe depression, since the differences in alexithymia scores became insignificant when corrected for depression rate. Likewise, [@B46] found that alexithymia, as well as somatization, depression, anxiety, and hostility, was significantly higher in a female FM sample compared with a CLBP group or healthy control group. Yet considering that difficulty in identifying and describing feelings reciprocally predicted depression and anxiety symptoms in the study, it is not clear whether alexithymia is a secondary defensive reaction against negative affects or a personality trait related to emotional trauma in women ([@B25]; [@B11]).

The results, at least partially contrasting, obtained in the studies mentioned above, might depend on different reasons. One could be related to the substantial individual differences in pain severity and disability in patients with persistent pain ([@B39]). In most cases, pain in FM is rated as more severe than in other chronic pain conditions ([@B47]). It is therefore important to compare FM patients with other chronic pain groups, after controlling for pain severity, since the differences in alexithymia levels may be influenced by variations in the experience of pain and disability ([@B27]).

Another possible reason could be the exclusive use of the TAS-20 for the assessment of alexithymia. In recent years, this instrument has been criticized for its inability to detect the most severe cases of alexithymia, the difficulty in replicating its factor structure, and its association with negative affectivity ([@B22]; [@B19]; [@B8]). Furthermore, the use of explicit self-reports as an exclusive measure to assess alexithymia has been questioned. Explicit self-reports require respondents to be aware of their lack of emotional awareness and reduced capacity to describe and identifying feelings ([@B35]). A better way to understand the construct could be the parallel use of a performance-based instrument (see for example the LEAS; [@B21]) or a structured interview, where individuals are not required to assess their own emotional abilities alone and the examiner determines the appropriate levels of emotional awareness through their descriptions ([@B4]).

ALEXITHYMIA AND PSYCHOLOGICAL DISTRESS IN FIBROMYALGIA SYNDROME
===============================================================

The presence of psychological distress, especially depression and anxiety, is a well-known aspect of FM syndrome and has been reported in many studies ([@B13]). At the same time, the increased prevalence of alexithymia in patients with depression is now well-established ([@B16]). It is therefore important to clarify whether or not the prevalence of alexithymia in FM patients can be accounted for simply by the presence of depressive symptoms. In the studies discussed above, the role of psychological distress, in particular depression, is highlighted in mediating the relationship between FM and alexithymia. As mentioned before, [@B41] found that the higher levels of alexithymia seen in FM patients were due only to the presence of moderate to severe depression, since the differences in alexithymia scores became insignificant when controlled for depression rate. On the other hand, [@B10], studying the quality of life in FM patients found, in both regression analyses performed, that when the psychological distress variables were added as competing predictors, alexithymia ceased to be significant in explaining the health-related quality of life variance. A possible interpretation, given by the authors, is that the inability of individuals with high degrees of alexithymia to identify accurately their own feelings limits not only their ability to regulate their emotions, but also verbal communication of psychological distress, with a potentially negative impact on depression and anxiety levels ([@B45]). Similarly, investigating the types of causal attributions in women with chronic pain, [@B46] found that the significant relationship between alexithymia scores, the number of somatic symptoms, and psychological attributions, in the FM group, became insignificant when the effects of psychological distress variables were controlled for. In other words, the former association appeared to be caused simply by the effects of depression and anxiety on the FM patients.

These results reveal the strong link between alexithymia and psychological distress in FM syndrome, especially depression. So it is essential for further research to consider the impact of alexithymia trait and its possible relationship with psychological distress and psychiatric disorders.

CONCLUSION
==========

Fibromyalgia is a multifaceted condition in which many factors are involved in the onset and retention of the disease. Psychological features are some of the principal aspects that contribute to the disability caused by this pathology and it is therefore essential to investigate them. Alexithymia is an emotional dysregulation trait, largely observed in psychosomatic disorders ([@B43]) that could play an important role in FM syndrome. Alexithymic individuals are, in fact, incapable of adequately identifying physical sensations such as the somatic manifestations of emotions and may tend to misinterpret their emotional arousal as signs of disease ([@B28]). This could amplify the perception of disease, bringing patients to seek medical care for symptoms for which there is no medical explanation.

The available studies show the high prevalence of alexithymic traits in FM patients, ranging from 15 to 20% ([@B36]; [@B10]). However, the unclear results found in some of these works indicate a need to shed light on the intensity and unambiguousness of this relationship. As mentioned before, there are two possible strategies for reaching this goal. One could be to use a performance-based instrument (see for example the LEAS; [@B21]) or a structured interview, in addition to commonly employed self-report measures (such as the TAS-20), for the assessment of alexithymia. The use of explicit self-reports requires, in fact, the respondents to be aware of their emotional dysregulation ([@B35]). The use of a performance-based instrument or a structured interview could represent a step forward toward a better understanding of this phenomena ([@B4]).

The other possibility is to use a control group of patients with chronic pain conditions with a low psychosomatic component (such as rheumatoid arthritis patients). The differences observed in alexithymia levels may be influenced by variations in the experience of pain, usually rated as more severe in FM syndrome than in other chronic pain diseases ([@B47]). So to better understand the prevalence of this psychological dimension in FM syndrome, it is important to compare FM patients with other chronic pain groups, after controlling for pain severity. An additional issue for further studies would be to analyze potential differences in the evolution of FM syndrome, with reference to the presence or absence of alexithymia. Specifically, it would be useful to investigate whether and how alexithymia influences the psychopathological symptoms, and the compliance to psychological and psychopharmacological interventions. Clarifying the role of alexithymia in FM can thus allow better understanding of the disease etiology and the development of patient-tailored treatments, in which both physical and psychological symptoms have to be considered.
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